Galectin Therapeutics, Inc. (GALT) saw a big move last session, as the company’s shares fell by over 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This stock, trading at a volatile range of $14.51–$17.05 in the past one-month time frame, showed a sharp decline yesterday at $13.58.
This drug development company has seen a flat track record when it comes to current year estimate revisions with no change over the past few weeks. The consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.
GALT currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.
Some better-ranked stocks in the Med-Drugs sector include Sucampo Pharmaceuticals, Inc. (SCMP), Lannett Company, Inc. (LCI) and Questcore Pharmaceuticals, Inc. (QCOR). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Be the first to comment